Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma
9m
·
The Lancet Diabetes & Endocrinology in conversation with
·
Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.
Read the full article:
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma
The episode Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma from the podcast The Lancet Diabetes & Endocrinology in conversation with has a duration of
9:42. It was first published
More episodes from The Lancet Diabetes & Endocrinology in conversation with
Márta Korbonits on mechanisms of ageing
Márta Korbonits talks with The Lancet Diabetes & Endocrinology about mechanisms of ageing: growth hormone, dietary restriction, and metformin.
Mirjam Christ-Crain and Cihan Atila on the patient's perspective of central diabetes insipidus
Mirjam Christ-Crain and Cihan Atila talk with The Lancet Diabetes & Endocrinology about central diabetes insipidus from a patient's perspective.
Read the full article:
Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey
Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma
Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.
Read the full article:
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma
Rossella Nappi on menopause as a turning point for women's health
Rossella Nappi talks with The Lancet Diabetes & Endocrinology about cardiometabolic changes that occur during the menopausal transition and implications for women’s health.
Read the full Series:
Menopause
Louise Baur on the causes of child and adolescent obesity
Louise Baur talks with The Lancet Diabetes & Endocrinology about the prevalence and causes of child and adolescent obesity, and the need for personalised treatment approaches.
Read the full article:
Obesity in children and adolescents: epidemiology, causes, assessment, and management